Delivery Order SPE2DB24D2101-SPE2DB24FKFJR

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $11,187.68 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation, to provide DUOVISC VISCOELASTIC SYSTEM 1.05ML medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $5,712.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of DUOVISC VISCOELASTIC SYSTEM 1.05ML, a medical product, with an ultimate completion date of April 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.12 firm fixed price delivery order is for the procurement of 4568180238 - DUOVISC VISCOELASTIC SYSTEM 0.75ML, with a period of performance through May 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a DUOVISC VISCOELASTIC SYSTEM 1.05ML product. The $5,300.20 firm fixed price contract has a completion date of February 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
This is a $31,798.64 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide a DUOVISC VISCOELASTIC SYSTEM 1.05ML. The contract has an ultimate completion date of May 21, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $5,372.85 to supply the DUOVISC VISCOELASTIC SYSTEM 1.05ML medical product. The award has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is an experienced prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
This is a $1,302.65 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the DUOVISC VISCOELASTIC SYSTEM 0.75ML medical product, with a performance period through March 27, 2025. The contract was not set aside for any specific socioeconomic program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide a DUOVISC VISCOELASTIC SYSTEM 1.05ML product. The $7,950.30 delivery order has a completion date of February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-asides associated with this award. This delivery order is issued under a larger $999,999,999.00...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the DUOVISC Viscoelastic System 1.05ML medical product. The $5,300.20 firm fixed price contract has a period of performance through June 25, 2024. This award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a "DUOVISC VISCOELASTIC SYSTEM 1.05ML" pharmaceutical product. The contract has a completion date of February 15, 2024 and a potential value of $3,324.20. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value up to...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFJR
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $1,308.83 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565213685 DUOVISC VISCOELASTIC SYSTEM 0.75ML. This order is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of essential medical commodities, including medications and supplies, to support various federal healthcare programs and military treatment facilities nationwide. This contract award does not have a set-aside designation and is expected to be completed by July 22, 2024.

Generated 10/18/24, 9:14 AM